Former Lancet Kenya Chief Executive Officer, Ahmed Kalebi, has suffered a legal setback after the High Court struck out key parts of his multi-billion shilling claim against the medical diagnostics firm.
Dr. Kalebi had moved to court seeking KSh 3.6 billion in compensation following his exit from Lancet Kenya. His claim covered a range of employment-related dues, including paid leave, overtime, gratuity, bonuses, and founder-linked benefits tied to his role in building the company.
However, the High Court ruled that it lacked jurisdiction to hear employment-related disputes, noting that such matters fall under the Employment and Labour Relations Court. As a result, those aspects of the claim were struck out.
The court’s decision narrows the scope of the ongoing case, leaving only commercial and shareholder-related issues before the High Court’s Commercial Division. These include disputes over equity ownership, shareholder rights, and claims of compensation arising from the alleged dilution of Dr. Kalebi’s shares following the company’s expansion across Africa.
Dr. Kalebi, who played a key role in establishing Lancet Kenya in 2009, maintains that he is entitled to substantial value as both a founder and shareholder. The company, however, argues that it fully compensated him for his shares at the time of his exit in 2016.
The case now proceeds with a sharper focus on the commercial dispute, as both parties continue to contest ownership and valuation claims tied to the company’s growth.
Related Content: Magistrate’s Court Defers Directions in Private Prosecution Bid Amid Procedural Disputes In JILK – KBL Case

